Plasma Resistin Concentration, Hepatic Fat Content, and Hepatic and Peripheral Insulin Resistance in Pioglitazone-Treated Type II Diabetic Patients
International Journal of Obesity - United Kingdom
doi 10.1038/sj.ijo.0802625
Full Text
Open PDFAbstract
Available in full text
Date
March 16, 2004
Authors
Publisher
Springer Science and Business Media LLC